Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
NeoPhotonics Corporation is a semiconductors business based in the US. NeoPhotonics Corporation shares (NPTN) are listed on the NYSE and all prices are listed in US Dollars. NeoPhotonics Corporation employs 1,200 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$9.52|
|52-week range||$6.15 - $14.14|
|50-day moving average||$9.06|
|200-day moving average||$9.77|
|Wall St. target price||$14.10|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.89|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||0.95%|
|1 month (2021-09-21)||11.48%|
|3 months (2021-07-21)||1.71%|
|6 months (2021-04-21)||-14.54%|
|1 year (2020-10-21)||41.67%|
|2 years (2019-10-21)||55.81%|
|3 years (2018-10-19)||12.66%|
|5 years (2016-10-21)||14.92|
Valuing NeoPhotonics Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NeoPhotonics Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
NeoPhotonics Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $13.7 million.
The EBITDA is a measure of a NeoPhotonics Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$296.5 million|
|Gross profit TTM||$108.6 million|
|Return on assets TTM||-6.93%|
|Return on equity TTM||-26.47%|
|Market capitalisation||$477.5 million|
TTM: trailing 12 months
There are currently 1.1 million NeoPhotonics Corporation shares held short by investors – that's known as NeoPhotonics Corporation's "short interest". This figure is 31.6% down from 1.6 million last month.
There are a few different ways that this level of interest in shorting NeoPhotonics Corporation shares can be evaluated.
NeoPhotonics Corporation's "short interest ratio" (SIR) is the quantity of NeoPhotonics Corporation shares currently shorted divided by the average quantity of NeoPhotonics Corporation shares traded daily (recently around 377347.70318021). NeoPhotonics Corporation's SIR currently stands at 2.83. In other words for every 100,000 NeoPhotonics Corporation shares traded daily on the market, roughly 2830 shares are currently held short.
However NeoPhotonics Corporation's short interest can also be evaluated against the total number of NeoPhotonics Corporation shares, or, against the total number of tradable NeoPhotonics Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NeoPhotonics Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 NeoPhotonics Corporation shares in existence, roughly 20 shares are currently held short) or 0.0211% of the tradable shares (for every 100,000 tradable NeoPhotonics Corporation shares, roughly 21 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NeoPhotonics Corporation.
Find out more about how you can short NeoPhotonics Corporation stock.
We're not expecting NeoPhotonics Corporation to pay a dividend over the next 12 months.
Over the last 12 months, NeoPhotonics Corporation's shares have ranged in value from as little as $6.15 up to $14.14. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while NeoPhotonics Corporation's is 0.9519. This would suggest that NeoPhotonics Corporation's shares are less volatile than average (for this exchange).
NeoPhotonics Corporation develops, manufactures, and sells optoelectronic products that transmit and receive high speed digital optical signals for cloud and hyperscale data center internet content provider and telecom networks worldwide. It offers high speed products, including transmitter, receiver, and switching products for 400G and optical transmission applications over distances of 2 to 2,000 kilometers; ultra-narrow linewidth tunable lasers that generate ultra-pure wavelength or color for coherent transmission; and integrated coherent receivers (ICRs) that decode the phase and polarization encoded coherent optical signals. The company also provides pluggable coherent transceivers that combine ultra-narrow linewidth laser with coherent receiver and performance coherent modulator; and 100G products for data center applications. In addition, it offers multi-cast switching solutions for 100G and above coherent systems; and network products and solutions, such as arrayed wavelength gratings, multiplexers, and filters used in dense wavelength division multiplexing systems. The company sells its products to network equipment manufacturers through a direct sales force in North America, Europe, and Asia. The company was formerly known as NanoGram Corporation and changed its name to NeoPhotonics Corporation in 2002. NeoPhotonics Corporation was founded in 1996 and is headquartered in San Jose, California.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.